Vice President — Pharmaceutical Division
The pharmaceutical industry is in a continuous state of change and constant scrutiny from health insurers, consumers, and the government, who require greater transparency and accountability. In recent times, industry challenges have been numerous as global health fears and economic regression due to the Covid-19 pandemic have taken center stage. Pharmaceutical companies are grappling with unfolding challenges arising from supply chain disruption and the need to change business processes. As the impacts of Covid-19 continue to unfold, pharma companies need to respond accordingly in order to recover, compete, and even thrive, depending on their current situation.